There were 1,668 press releases posted in the last 24 hours and 413,749 in the last 365 days.

Injectable Drug Delivery Market to Exhibit a Remarkable CAGR of 12.8%, EVER NEURO PHARMA GMBH’s Launch of Novel Drug Delivery Device for Parkinson’s Patients to Aid Expansion: Fortune Business Insights

Key companies covered in the Injectable Drug Delivery Market Research report include SHL Group, BD, Insulet Corporation, Pfizer Inc., Eli Lilly and Company, Elcam Medical, Ypsomed AG, West Pharmaceutical Services, Inc., and Gerresheimer AG.

Pune, July 31, 2019 (GLOBE NEWSWIRE) -- A study by the American Diabetes Association (ADA) has found that around 30.3 million people in the U.S. were diagnosed with diabetes. The rising prevalence of chronic diseases such as diabetes, cancer, and others is boosting the global Injectable Drug Delivery Market. Fortune Business Insights in a report, titledINJECTABLE DRUG DELIVERY MARKET: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts the global market to rise at a remarkable CAGR of 12.8% during the forecast period. The global market was worth US$ 440.5 Bn in 2018, and by the end of 2026, the market is anticipated to reach US$ 1,135.1 Bn.


Browse Complete Report Details with Table of Content and Figures:
https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044


Introduction of Novel Injectable Drug Delivery to Propel Growth in North America

Currently, the market in North America is exhibiting the highest CAGR owing to the rapid adoption of advanced and innovative injectable drug delivery. Moreover, injectable drug users are increasing as these devices are preferred owing to their therapeutic and convenience benefits. The amplified prevalence of chronic disorders such as cancer, diabetes, and others is driving the Injectable Drug Delivery Market size in North America. As per the National Cancer Institute, around 1,735,350 cancer cases were registered in the U.S. With the help of an injectable device; chemotherapy drugs are delivered to cancer patients with ease. Another factor responsible for injectable drug delivery growth is the presence of major manufacturers in North America. This further increases the adoption of injectable drug delivery systems. These manufacturers are planning to develop innovative drug delivery such as auto-injectors, smart wearables, among others in the years to come. Against this backdrop, the market is likely to grow in the forecast period in North America. As per the report, the market was valued at US$ 156.8 Bn in the year 2018.

Apart from North America, the market in Asia Pacific is also anticipated to exhibit a high CAGR in the forecast years. Increasing patient population and rising awareness about the benefits offered by injectable drug delivery are enabling growth in the market in this region.

Advances in Injectable Drug Devices Focuses on Simplifying their Usage in Complex Procedures

“Traditional drug delivery are more prone to infections owing to their mishandling. This can be minimized by adopting reusable glass syringes and pre-filled syringes,” said a lead analyst at Fortune Business Insights. “These smart and advanced devices have proven to be highly effective and safe for humans, which fuels their demand in the market,” he added.

Advances in technology and design of injectable drug delivery are aimed at simplifying their usage during complex drug delivery procedures. The introduction of next-generation drug delivery offering high-quality and superior functionalities acts as a potential growth trigger. Such technological improvements will enhance patient compliance and simultaneously make it easier for clinicians to perform the injectable drug delivery procedure. This, together with the rising focus on biologics in the pharmaceutical sector, is anticipated to facilitate growth in the market.


Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-drug-delivery-market-101044


BD Leads the Market Owing to its Vast Product Portfolio

Among key players, Becton Dickinson boasts an innovative and vast product portfolio which includes pen-injectors, auto-injectors, and others. The company is leading in the global Injectable Drug Delivery Market, mainly on account of its global presence. Other companies are focusing on product innovations to expand their market shares. The key players profiled in the report are SHL Group, BD, Insulet Corporation, Pfizer Inc., Eli Lilly and Company, Elcam Medical, Ypsomed AG, West Pharmaceutical Services, Inc., and Gerresheimer AG. Of these, BD, SHL, and Insulet Corporation hold the maximum share in the global market. The strong presence of these companies will surge the injectable drug delivery revenue in the forecast years. Some of the notable industry developments made by companies which will help the market to grow are:

  • West Pharmaceutical Services, Inc., launched a new extension of SMARTDOSE drug delivery platform in November 2017.
  • AbbVie Inc. and Eisai Co., Ltd., together announced the launch of an auto-injector device in June 2018. This device is for Humira drug for the treatment of autoimmune diseases.
  • EVER NEURO PHARMA GMBH launched D-MINE pump for patients suffering from Parkinson’s disease in July 2019.  The device is convenient to use and aims to provide continuous subcutaneous drug delivery.

Injectable Drug Delivery Market Players

  • BD
  • SHL Group
  • Insulet Corporation
  • Elcam Medical
  • Pfizer Inc.
  • Eli Lilly and Company
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Gerresheimer AG
  • Others


Speak to Analyst  https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/injectable-drug-delivery-market-101044


Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities

  • Key Insights
    • Prevalence of key diseases - For key countries, 2018
    • New product launch
    • Overview of technological advancements in injectable drug delivery devices
    • Pricing analysis
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018

  • Global Injectable Drug Delivery Devices Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Device Type
      • Conventional Injectable
      • Pre-filled Syringes
      • Auto-injectors
      • Pen-injectors
      • Wearables
    • Market Analysis, Insights and Forecast – By Application
      • Autoimmune Disorders
      • Diabetes
      • Pain Management
      • Aesthetic Treatments
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Subcutaneous
      • Intravenous
      • Intramuscular
      • Others
    • Market Analysis, Insights and Forecast – By End-User
      • Hospitals
      • Home Care Settings
      • Clinics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa
  • Competitive Analysis
  • Strategic Recommendations


Request for Customization:    https://www.fortunebusinessinsights.com/enquiry/customization/injectable-drug-delivery-market-101044


Browse Related Reports:

  • Connected Drug Delivery Devices Market Size, Share and Global Trend by Product Type (Sensors, Integrated devices), Application (Diabetes, Multiple Sclerosis, Asthma and COPD, Hypertension), End Users (Home Care Settings, Hospitals, Surgical Centers) and Geography Forecast till 2026

  • Pulmonary Drug Delivery Systems Market Size, Share and Global Trend by Types (Inhalers, Nebulizers), By Application (Cystic Fibrosis, Asthma, Chronic Obstructive Pulmonary Disorder (COPD)), By Age Group (Adult, Pediatric), By End User (Hospitals, Specialty Clinics, Home Care Services), and Geography Forecast till 2026

  • Needle-free Drug Delivery Technology Market Size, Share and Global Trend by Product (Inhaler, Jet Injector, Novel Needles, Transdermal Patch), By Application (Vaccine Delivery, Pain Management, Insulin Delivery), By End Users (Hospitals & Clinics, Homecare Settings, Research Laboratories, Academics), and Geography Forecast till 2026

  • Bioadhesive Microspheres Market Size, Share and Global Trend by Material (Natural Polymers, Synthetic Polymers), By Route of Drug Delivery (Oral, Nasal, Ocular, Colorectal), By End Users (Hospitals, Clinics, Academic & Research Institutes, Pharmaceutical & Biotechnology Industries), and Geography Forecast till 2026


About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com 
Website: https://www.fortunebusinessinsights.com

Primary Logo